• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸咖啡因维持剂量对早产儿拔管和通气后呼吸暂停的影响。

Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants.

机构信息

Department of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Laboratory of Neonatal Disease, Institute of Pediatrics, Central South University, Changsha, Hunan, China.

出版信息

Pediatr Pulmonol. 2020 Oct;55(10):2635-2640. doi: 10.1002/ppul.24948. Epub 2020 Jul 15.

DOI:10.1002/ppul.24948
PMID:32639634
Abstract

BACKGROUND

Caffeine citrate is used to prevent apnea in premature infants and help in extubation of invasive ventilation, but the optimal dose remains undetermined.

METHODS

Neonates born at less than 30 weeks gestation who had received invasive ventilation for at least 48 hours and a loading dose of 20 mg/kg caffeine citrate were randomly assigned into high (10 mg/kg daily) or low (5 mg/kg daily) maintenance dose groups. The drug was discontinued if no apnea occurred for 7 consecutive days.

RESULTS

A total of 111 infants were assigned into the high (54) or low (57) dose groups. Extubation failure (16.7% vs 36.8%), age of extubation (8.2 ± 2.1 vs 10.7 ± 2.3 day), duration of invasive ventilation (7.2 ± 2.1 vs 8.5 ± 2.4 day), duration of ventilation before extubation (8.0 ± 1.8 vs 10.1 ± 1.9 day), and number of days of apnea (1.8 ± 1.3 vs 3.2 ± 1.1 day) were significantly lower in the high dose group than the low dose group. Difference in time until failure (6.7 ± 1.7d vs 7.0 ± 1.9d) and duration of nasal continuous positive airway pressure(7.8 ± 1.8 vs 8.0 ± 2.2 day) were not significant. Furthermore, no significant differences in the incidence of tachycardia (9.3% vs 12.3%), abdominal distension (16.7% vs 12.3%), feeding intolerance (3.7% vs 5.3%), or irritability (7.4% vs 5.3%) were observed between groups.

CONCLUSIONS

A higher maintenance dose of caffeine citrate reduced the incidence of extubation failure and apnea of prematurity without increasing the occurrence of adverse reactions.

摘要

背景

枸橼酸咖啡因被用于预防早产儿呼吸暂停和帮助有创通气撤机,但最佳剂量仍未确定。

方法

胎龄小于 30 周、接受至少 48 小时有创通气且已给予负荷剂量 20mg/kg 枸橼酸咖啡因的新生儿,随机分为高(10mg/kg/d)或低(5mg/kg/d)维持剂量组。如果连续 7 天无呼吸暂停,则停止用药。

结果

共有 111 名婴儿被分配到高(54 名)或低(57 名)剂量组。与低剂量组相比,高剂量组拔管失败率(16.7%比 36.8%)、拔管时龄(8.2±2.1 天比 10.7±2.3 天)、有创通气时间(7.2±2.1 天比 8.5±2.4 天)、拔管前通气时间(8.0±1.8 天比 10.1±1.9 天)和呼吸暂停天数(1.8±1.3 天比 3.2±1.1 天)显著降低。两组间到达失败的时间差异(6.7±1.7d 比 7.0±1.9d)和鼻塞持续气道正压通气时间(7.8±1.8 天比 8.0±2.2 天)无显著差异。此外,两组间心动过速(9.3%比 12.3%)、腹胀(16.7%比 12.3%)、喂养不耐受(3.7%比 5.3%)或烦躁(7.4%比 5.3%)的发生率也无显著差异。

结论

枸橼酸咖啡因维持剂量较高可降低早产儿拔管失败和呼吸暂停的发生率,而不增加不良反应的发生。

相似文献

1
Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants.枸橼酸咖啡因维持剂量对早产儿拔管和通气后呼吸暂停的影响。
Pediatr Pulmonol. 2020 Oct;55(10):2635-2640. doi: 10.1002/ppul.24948. Epub 2020 Jul 15.
2
High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.高剂量与低剂量咖啡因治疗早产儿呼吸暂停:一项随机对照试验。
Eur J Pediatr. 2015 Jul;174(7):949-56. doi: 10.1007/s00431-015-2494-8. Epub 2015 Feb 3.
3
Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study.咖啡因日剂量与早产儿呼吸结局的关系:一项回顾性队列研究。
Inquiry. 2024 Jan-Dec;61:469580241248098. doi: 10.1177/00469580241248098.
4
[Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].不同剂量咖啡因治疗早产儿原发性呼吸暂停的临床疗效
Zhonghua Er Ke Za Zhi. 2016 Jan;54(1):33-6. doi: 10.3760/cma.j.issn.0578-1310.2016.01.008.
5
High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial.高剂量枸橼酸咖啡因用于早产儿拔管:一项随机对照试验。
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F499-503. doi: 10.1136/adc.2002.023432.
6
Periextubation caffeine in preterm neonates: a randomized dose response trial.早产儿拔管后使用咖啡因:一项随机剂量反应试验。
J Paediatr Child Health. 2003 Sep-Oct;39(7):511-5. doi: 10.1046/j.1440-1754.2003.00207.x.
7
Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis.不同剂量枸橼酸咖啡因维持治疗早产儿呼吸暂停的疗效和安全性的系统评价和 Meta 分析。
Biomed Res Int. 2018 Dec 24;2018:9061234. doi: 10.1155/2018/9061234. eCollection 2018.
8
Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.将药效学因素纳入早产儿咖啡因治疗药物监测中。
BMC Pharmacol Toxicol. 2016 Jun 7;17(1):22. doi: 10.1186/s40360-016-0065-x.
9
[Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].国产与进口枸橼酸咖啡因治疗早产儿呼吸暂停疗效比较:一项前瞻性随机双盲对照试验
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Jul;22(7):684-689. doi: 10.7499/j.issn.1008-8830.2003276.
10
Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.枸橼酸咖啡因预防对伴有呼吸暂停的早产儿细胞因子谱和支气管肺发育不良的影响。
Minerva Pediatr. 2020 Apr;72(2):95-100. doi: 10.23736/S0026-4946.19.05428-8. Epub 2019 Apr 5.

引用本文的文献

1
Caffeine use in preterm neonates: national insights into Turkish NICU practices.早产新生儿咖啡因的使用:对土耳其新生儿重症监护病房实践的全国性洞察。
Front Pediatr. 2025 Feb 27;13:1492716. doi: 10.3389/fped.2025.1492716. eCollection 2025.
2
Clinical efficacy of different maintenance doses of caffeine citrate in the treatment of apnea of prematurity.不同维持剂量的枸橼酸咖啡因治疗早产儿呼吸暂停的临床疗效
Pak J Med Sci. 2025 Feb;41(2):478-483. doi: 10.12669/pjms.41.2.9692.
3
The effect of an additional pre-extubational loading dose of caffeine citrate on mechanically ventilated preterm infants (NEOKOFF trial): Study protocol for a multicenter randomized clinical trial.
额外给予枸橼酸咖啡因拔管前负荷剂量对机械通气早产儿的影响(NEOKOFF试验):一项多中心随机临床试验的研究方案
PLoS One. 2025 Jan 13;20(1):e0315856. doi: 10.1371/journal.pone.0315856. eCollection 2025.
4
Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study.咖啡因日剂量与早产儿呼吸结局的关系:一项回顾性队列研究。
Inquiry. 2024 Jan-Dec;61:469580241248098. doi: 10.1177/00469580241248098.
5
Methylxanthine for the prevention and treatment of apnea in preterm infants.甲基黄嘌呤预防和治疗早产儿呼吸暂停。
Cochrane Database Syst Rev. 2023 Oct 31;10(10):CD013830. doi: 10.1002/14651858.CD013830.pub2.
6
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.咖啡因给药方案在早产儿或有早产儿呼吸暂停风险的婴儿中的应用。
Cochrane Database Syst Rev. 2023 Apr 11;4(4):CD013873. doi: 10.1002/14651858.CD013873.pub2.
7
Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study.不同维持剂量枸橼酸咖啡因治疗需要辅助通气的早产儿的临床效果:一项多中心初步研究。
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Mar 15;24(3):240-248. doi: 10.7499/j.issn.1008-8830.2109144.
8
Treating Apnea of Prematurity.治疗早产儿呼吸暂停。
Cureus. 2022 Jan 31;14(1):e21783. doi: 10.7759/cureus.21783. eCollection 2022 Jan.
9
Effect of different maintenance doses of caffeine citrate on ventilator weaning in very preterm infants with respiratory distress syndrome: a prospective randomized controlled trial.枸橼酸咖啡因不同维持剂量对呼吸窘迫综合征极早产儿呼吸机撤机的影响:一项前瞻性随机对照试验。
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Nov 15;23(11):1097-1102. doi: 10.7499/j.issn.1008-8830.2107167.
10
Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors.用于新生儿重症监护病房(NICU)中早产儿呼吸暂停药物治疗的咖啡因:剂量选择难题、治疗药物监测及遗传因素
Front Pharmacol. 2021 Jul 26;12:681842. doi: 10.3389/fphar.2021.681842. eCollection 2021.